Table of Content

1 Transdermal Analgesic Patch Market Overview
1.1 Product Overview and Scope of Transdermal Analgesic Patch
1.2 Transdermal Analgesic Patch Segment by Type
1.2.1 Global Transdermal Analgesic Patch Market Value Comparison by Type (2024-2034)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Transdermal Analgesic Patch Segment by Application
1.3.1 Global Transdermal Analgesic Patch Market Value by Application: (2024-2034)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Analgesic Patch Market Size Estimates and Forecasts
1.4.1 Global Transdermal Analgesic Patch Revenue 2024-2034
1.4.2 Global Transdermal Analgesic Patch Sales 2024-2034
1.4.3 Global Transdermal Analgesic Patch Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Transdermal Analgesic Patch Market Competition by Manufacturers
2.1 Global Transdermal Analgesic Patch Sales Market Share by Manufacturers (2024-2024)
2.2 Global Transdermal Analgesic Patch Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Transdermal Analgesic Patch Average Price by Manufacturers (2024-2024)
2.4 Global Transdermal Analgesic Patch Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Transdermal Analgesic Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal Analgesic Patch, Product Type & Application
2.7 Transdermal Analgesic Patch Market Competitive Situation and Trends
2.7.1 Transdermal Analgesic Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal Analgesic Patch Players Market Share by Revenue
2.7.3 Global Transdermal Analgesic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal Analgesic Patch Retrospective Market Scenario by Region
3.1 Global Transdermal Analgesic Patch Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Transdermal Analgesic Patch Global Transdermal Analgesic Patch Sales by Region: 2024-2034
3.2.1 Global Transdermal Analgesic Patch Sales by Region: 2024-2024
3.2.2 Global Transdermal Analgesic Patch Sales by Region: 2024-2034
3.3 Global Transdermal Analgesic Patch Global Transdermal Analgesic Patch Revenue by Region: 2024-2034
3.3.1 Global Transdermal Analgesic Patch Revenue by Region: 2024-2024
3.3.2 Global Transdermal Analgesic Patch Revenue by Region: 2024-2034
3.4 North America Transdermal Analgesic Patch Market Facts & Figures by Country
3.4.1 North America Transdermal Analgesic Patch Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Transdermal Analgesic Patch Sales by Country (2024-2034)
3.4.3 North America Transdermal Analgesic Patch Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Analgesic Patch Market Facts & Figures by Country
3.5.1 Europe Transdermal Analgesic Patch Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Transdermal Analgesic Patch Sales by Country (2024-2034)
3.5.3 Europe Transdermal Analgesic Patch Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Analgesic Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal Analgesic Patch Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Transdermal Analgesic Patch Sales by Country (2024-2034)
3.6.3 Asia Pacific Transdermal Analgesic Patch Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Transdermal Analgesic Patch Market Facts & Figures by Country
3.7.1 Latin America Transdermal Analgesic Patch Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Transdermal Analgesic Patch Sales by Country (2024-2034)
3.7.3 Latin America Transdermal Analgesic Patch Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal Analgesic Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Analgesic Patch Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Transdermal Analgesic Patch Sales by Country (2024-2034)
3.8.3 Middle East and Africa Transdermal Analgesic Patch Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Analgesic Patch Sales by Type (2024-2034)
4.1.1 Global Transdermal Analgesic Patch Sales by Type (2024-2024)
4.1.2 Global Transdermal Analgesic Patch Sales by Type (2024-2034)
4.1.3 Global Transdermal Analgesic Patch Sales Market Share by Type (2024-2034)
4.2 Global Transdermal Analgesic Patch Revenue by Type (2024-2034)
4.2.1 Global Transdermal Analgesic Patch Revenue by Type (2024-2024)
4.2.2 Global Transdermal Analgesic Patch Revenue by Type (2024-2034)
4.2.3 Global Transdermal Analgesic Patch Revenue Market Share by Type (2024-2034)
4.3 Global Transdermal Analgesic Patch Price by Type (2024-2034)
5 Segment by Application
5.1 Global Transdermal Analgesic Patch Sales by Application (2024-2034)
5.1.1 Global Transdermal Analgesic Patch Sales by Application (2024-2024)
5.1.2 Global Transdermal Analgesic Patch Sales by Application (2024-2034)
5.1.3 Global Transdermal Analgesic Patch Sales Market Share by Application (2024-2034)
5.2 Global Transdermal Analgesic Patch Revenue by Application (2024-2034)
5.2.1 Global Transdermal Analgesic Patch Revenue by Application (2024-2024)
5.2.2 Global Transdermal Analgesic Patch Revenue by Application (2024-2034)
5.2.3 Global Transdermal Analgesic Patch Revenue Market Share by Application (2024-2034)
5.3 Global Transdermal Analgesic Patch Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Description and Business Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Hisamitsu Pharmaceutical Transdermal Analgesic Patch Product Portfolio
6.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Johnson & Johnson Transdermal Analgesic Patch Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Mylan Transdermal Analgesic Patch Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Description and Business Overview
6.4.3 UCB Pharma Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.4.4 UCB Pharma Transdermal Analgesic Patch Product Portfolio
6.4.5 UCB Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Novartis Transdermal Analgesic Patch Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Teva Pharmaceutical Transdermal Analgesic Patch Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Beijing Tide Pharmaceutical
6.6.1 Beijing Tide Pharmaceutical Corporation Information
6.6.2 Beijing Tide Pharmaceutical Description and Business Overview
6.6.3 Beijing Tide Pharmaceutical Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Beijing Tide Pharmaceutical Transdermal Analgesic Patch Product Portfolio
6.7.5 Beijing Tide Pharmaceutical Recent Developments/Updates
6.8 Chattem
6.8.1 Chattem Corporation Information
6.8.2 Chattem Description and Business Overview
6.8.3 Chattem Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Chattem Transdermal Analgesic Patch Product Portfolio
6.8.5 Chattem Recent Developments/Updates
6.9 Nitto Denko
6.9.1 Nitto Denko Corporation Information
6.9.2 Nitto Denko Description and Business Overview
6.9.3 Nitto Denko Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Nitto Denko Transdermal Analgesic Patch Product Portfolio
6.9.5 Nitto Denko Recent Developments/Updates
6.10 Grünenthal
6.10.1 Grünenthal Corporation Information
6.10.2 Grünenthal Description and Business Overview
6.10.3 Grünenthal Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Grünenthal Transdermal Analgesic Patch Product Portfolio
6.10.5 Grünenthal Recent Developments/Updates
6.11 Mundipharma
6.11.1 Mundipharma Corporation Information
6.11.2 Mundipharma Transdermal Analgesic Patch Description and Business Overview
6.11.3 Mundipharma Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Mundipharma Transdermal Analgesic Patch Product Portfolio
6.11.5 Mundipharma Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Transdermal Analgesic Patch Description and Business Overview
6.12.3 GSK Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.12.4 GSK Transdermal Analgesic Patch Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Luye Pharma Group
6.13.1 Luye Pharma Group Corporation Information
6.13.2 Luye Pharma Group Transdermal Analgesic Patch Description and Business Overview
6.13.3 Luye Pharma Group Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.13.4 Luye Pharma Group Transdermal Analgesic Patch Product Portfolio
6.13.5 Luye Pharma Group Recent Developments/Updates
6.14 Bayer
6.14.1 Bayer Corporation Information
6.14.2 Bayer Transdermal Analgesic Patch Description and Business Overview
6.14.3 Bayer Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Bayer Transdermal Analgesic Patch Product Portfolio
6.14.5 Bayer Recent Developments/Updates
6.15 IBSA Group
6.15.1 IBSA Group Corporation Information
6.15.2 IBSA Group Transdermal Analgesic Patch Description and Business Overview
6.15.3 IBSA Group Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.15.4 IBSA Group Transdermal Analgesic Patch Product Portfolio
6.15.5 IBSA Group Recent Developments/Updates
6.16 Dr Reddy’s Laboratories
6.16.1 Dr Reddy’s Laboratories Corporation Information
6.16.2 Dr Reddy’s Laboratories Transdermal Analgesic Patch Description and Business Overview
6.16.3 Dr Reddy’s Laboratories Transdermal Analgesic Patch Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Dr Reddy’s Laboratories Transdermal Analgesic Patch Product Portfolio
6.16.5 Dr Reddy’s Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Analgesic Patch Industry Chain Analysis
7.2 Transdermal Analgesic Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Analgesic Patch Production Mode & Process
7.4 Transdermal Analgesic Patch Sales and Marketing
7.4.1 Transdermal Analgesic Patch Sales Channels
7.4.2 Transdermal Analgesic Patch Distributors
7.5 Transdermal Analgesic Patch Customers
8 Transdermal Analgesic Patch Market Dynamics
8.1 Transdermal Analgesic Patch Industry Trends
8.2 Transdermal Analgesic Patch Market Drivers
8.3 Transdermal Analgesic Patch Market Challenges
8.4 Transdermal Analgesic Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Transdermal Analgesic Patch Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Transdermal Analgesic Patch Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Transdermal Analgesic Patch Market Competitive Situation by Manufacturers in 2022
Table 4. Global Transdermal Analgesic Patch Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Transdermal Analgesic Patch Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Transdermal Analgesic Patch Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Transdermal Analgesic Patch Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Transdermal Analgesic Patch Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Transdermal Analgesic Patch, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Transdermal Analgesic Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Transdermal Analgesic Patch, Product Type & Application
Table 12. Global Key Manufacturers of Transdermal Analgesic Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Transdermal Analgesic Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Analgesic Patch as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Transdermal Analgesic Patch Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Transdermal Analgesic Patch Sales by Region (2024-2024) & (K Units)
Table 18. Global Transdermal Analgesic Patch Sales Market Share by Region (2024-2024)
Table 19. Global Transdermal Analgesic Patch Sales by Region (2024-2034) & (K Units)
Table 20. Global Transdermal Analgesic Patch Sales Market Share by Region (2024-2034)
Table 21. Global Transdermal Analgesic Patch Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Transdermal Analgesic Patch Revenue Market Share by Region (2024-2024)
Table 23. Global Transdermal Analgesic Patch Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Transdermal Analgesic Patch Revenue Market Share by Region (2024-2034)
Table 25. North America Transdermal Analgesic Patch Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Transdermal Analgesic Patch Sales by Country (2024-2024) & (K Units)
Table 27. North America Transdermal Analgesic Patch Sales by Country (2024-2034) & (K Units)
Table 28. North America Transdermal Analgesic Patch Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Transdermal Analgesic Patch Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Transdermal Analgesic Patch Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Transdermal Analgesic Patch Sales by Country (2024-2024) & (K Units)
Table 32. Europe Transdermal Analgesic Patch Sales by Country (2024-2034) & (K Units)
Table 33. Europe Transdermal Analgesic Patch Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Transdermal Analgesic Patch Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Transdermal Analgesic Patch Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Transdermal Analgesic Patch Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Transdermal Analgesic Patch Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Transdermal Analgesic Patch Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Transdermal Analgesic Patch Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Transdermal Analgesic Patch Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Transdermal Analgesic Patch Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Transdermal Analgesic Patch Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Transdermal Analgesic Patch Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Transdermal Analgesic Patch Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Transdermal Analgesic Patch Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Transdermal Analgesic Patch Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Transdermal Analgesic Patch Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Transdermal Analgesic Patch Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Transdermal Analgesic Patch Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Transdermal Analgesic Patch Sales (K Units) by Type (2024-2024)
Table 51. Global Transdermal Analgesic Patch Sales (K Units) by Type (2024-2034)
Table 52. Global Transdermal Analgesic Patch Sales Market Share by Type (2024-2024)
Table 53. Global Transdermal Analgesic Patch Sales Market Share by Type (2024-2034)
Table 54. Global Transdermal Analgesic Patch Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Transdermal Analgesic Patch Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Transdermal Analgesic Patch Revenue Market Share by Type (2024-2024)
Table 57. Global Transdermal Analgesic Patch Revenue Market Share by Type (2024-2034)
Table 58. Global Transdermal Analgesic Patch Price (US$/Unit) by Type (2024-2024)
Table 59. Global Transdermal Analgesic Patch Price (US$/Unit) by Type (2024-2034)
Table 60. Global Transdermal Analgesic Patch Sales (K Units) by Application (2024-2024)
Table 61. Global Transdermal Analgesic Patch Sales (K Units) by Application (2024-2034)
Table 62. Global Transdermal Analgesic Patch Sales Market Share by Application (2024-2024)
Table 63. Global Transdermal Analgesic Patch Sales Market Share by Application (2024-2034)
Table 64. Global Transdermal Analgesic Patch Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Transdermal Analgesic Patch Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Transdermal Analgesic Patch Revenue Market Share by Application (2024-2024)
Table 67. Global Transdermal Analgesic Patch Revenue Market Share by Application (2024-2034)
Table 68. Global Transdermal Analgesic Patch Price (US$/Unit) by Application (2024-2024)
Table 69. Global Transdermal Analgesic Patch Price (US$/Unit) by Application (2024-2034)
Table 70. Hisamitsu Pharmaceutical Corporation Information
Table 71. Hisamitsu Pharmaceutical Description and Business Overview
Table 72. Hisamitsu Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Hisamitsu Pharmaceutical Transdermal Analgesic Patch Product
Table 74. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Johnson & Johnson Transdermal Analgesic Patch Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Mylan Transdermal Analgesic Patch Product
Table 84. Mylan Recent Developments/Updates
Table 85. UCB Pharma Corporation Information
Table 86. UCB Pharma Description and Business Overview
Table 87. UCB Pharma Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. UCB Pharma Transdermal Analgesic Patch Product
Table 89. UCB Pharma Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Novartis Transdermal Analgesic Patch Product
Table 94. Novartis Recent Developments/Updates
Table 95. Teva Pharmaceutical Corporation Information
Table 96. Teva Pharmaceutical Description and Business Overview
Table 97. Teva Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Teva Pharmaceutical Transdermal Analgesic Patch Product
Table 99. Teva Pharmaceutical Recent Developments/Updates
Table 100. Beijing Tide Pharmaceutical Corporation Information
Table 101. Beijing Tide Pharmaceutical Description and Business Overview
Table 102. Beijing Tide Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Beijing Tide Pharmaceutical Transdermal Analgesic Patch Product
Table 104. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 105. Chattem Corporation Information
Table 106. Chattem Description and Business Overview
Table 107. Chattem Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Chattem Transdermal Analgesic Patch Product
Table 109. Chattem Recent Developments/Updates
Table 110. Nitto Denko Corporation Information
Table 111. Nitto Denko Description and Business Overview
Table 112. Nitto Denko Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Nitto Denko Transdermal Analgesic Patch Product
Table 114. Nitto Denko Recent Developments/Updates
Table 115. Grünenthal Corporation Information
Table 116. Grünenthal Description and Business Overview
Table 117. Grünenthal Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Grünenthal Transdermal Analgesic Patch Product
Table 119. Grünenthal Recent Developments/Updates
Table 120. Mundipharma Corporation Information
Table 121. Mundipharma Description and Business Overview
Table 122. Mundipharma Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Mundipharma Transdermal Analgesic Patch Product
Table 124. Mundipharma Recent Developments/Updates
Table 125. GSK Corporation Information
Table 126. GSK Description and Business Overview
Table 127. GSK Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. GSK Transdermal Analgesic Patch Product
Table 129. GSK Recent Developments/Updates
Table 130. Luye Pharma Group Corporation Information
Table 131. Luye Pharma Group Description and Business Overview
Table 132. Luye Pharma Group Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Luye Pharma Group Transdermal Analgesic Patch Product
Table 134. Luye Pharma Group Recent Developments/Updates
Table 135. Bayer Corporation Information
Table 136. Bayer Description and Business Overview
Table 137. Bayer Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Bayer Transdermal Analgesic Patch Product
Table 139. Bayer Recent Developments/Updates
Table 140. IBSA Group Corporation Information
Table 141. IBSA Group Description and Business Overview
Table 142. IBSA Group Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. IBSA Group Transdermal Analgesic Patch Product
Table 144. IBSA Group Recent Developments/Updates
Table 145. Dr Reddy’s Laboratories Corporation Information
Table 146. Dr Reddy’s Laboratories Description and Business Overview
Table 147. Dr Reddy’s Laboratories Transdermal Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Dr Reddy’s Laboratories Transdermal Analgesic Patch Product
Table 149. Dr Reddy’s Laboratories Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Transdermal Analgesic Patch Distributors List
Table 153. Transdermal Analgesic Patch Customers List
Table 154. Transdermal Analgesic Patch Market Trends
Table 155. Transdermal Analgesic Patch Market Drivers
Table 156. Transdermal Analgesic Patch Market Challenges
Table 157. Transdermal Analgesic Patch Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Transdermal Analgesic Patch
Figure 2. Global Transdermal Analgesic Patch Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Transdermal Analgesic Patch Market Share by Type in 2022 & 2034
Figure 4. Methyl Salicylate-based Patch Product Picture
Figure 5. Rivastigmine Transdermal Patch Product Picture
Figure 6. Fentanyl Transdermal Patch Product Picture
Figure 7. Lidocaine Patch Product Picture
Figure 8. Diclofenac Patch Product Picture
Figure 9. Nicotine Transdermal Patch Product Picture
Figure 10. Others Product Picture
Figure 11. Global Transdermal Analgesic Patch Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 12. Global Transdermal Analgesic Patch Market Share by Application in 2022 & 2034
Figure 13. Rx Channel
Figure 14. OTC Channel
Figure 15. Global Transdermal Analgesic Patch Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 16. Global Transdermal Analgesic Patch Market Size (2024-2034) & (US$ Million)
Figure 17. Global Transdermal Analgesic Patch Sales (2024-2034) & (K Units)
Figure 18. Global Transdermal Analgesic Patch Average Price (US$/Unit) & (2024-2034)
Figure 19. Transdermal Analgesic Patch Report Years Considered
Figure 20. Transdermal Analgesic Patch Sales Share by Manufacturers in 2022
Figure 21. Global Transdermal Analgesic Patch Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest Transdermal Analgesic Patch Players: Market Share by Revenue in 2022
Figure 23. Transdermal Analgesic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 24. Global Transdermal Analgesic Patch Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 25. North America Transdermal Analgesic Patch Sales Market Share by Country (2024-2034)
Figure 26. North America Transdermal Analgesic Patch Revenue Market Share by Country (2024-2034)
Figure 27. United States Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Canada Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. Europe Transdermal Analgesic Patch Sales Market Share by Country (2024-2034)
Figure 30. Europe Transdermal Analgesic Patch Revenue Market Share by Country (2024-2034)
Figure 31. Germany Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. France Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. U.K. Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Italy Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Russia Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Asia Pacific Transdermal Analgesic Patch Sales Market Share by Region (2024-2034)
Figure 37. Asia Pacific Transdermal Analgesic Patch Revenue Market Share by Region (2024-2034)
Figure 38. China Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Japan Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. South Korea Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. India Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Australia Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. China Taiwan Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Latin America Transdermal Analgesic Patch Sales Market Share by Country (2024-2034)
Figure 46. Latin America Transdermal Analgesic Patch Revenue Market Share by Country (2024-2034)
Figure 47. Mexico Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Brazil Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Argentina Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Transdermal Analgesic Patch Sales Market Share by Country (2024-2034)
Figure 51. Middle East & Africa Transdermal Analgesic Patch Revenue Market Share by Country (2024-2034)
Figure 52. Turkey Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. UAE Transdermal Analgesic Patch Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Transdermal Analgesic Patch by Type (2024-2034)
Figure 56. Global Revenue Market Share of Transdermal Analgesic Patch by Type (2024-2034)
Figure 57. Global Transdermal Analgesic Patch Price (US$/Unit) by Type (2024-2034)
Figure 58. Global Sales Market Share of Transdermal Analgesic Patch by Application (2024-2034)
Figure 59. Global Revenue Market Share of Transdermal Analgesic Patch by Application (2024-2034)
Figure 60. Global Transdermal Analgesic Patch Price (US$/Unit) by Application (2024-2034)
Figure 61. Transdermal Analgesic Patch Value Chain
Figure 62. Transdermal Analgesic Patch Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed